Gel-one
Products billed under this code include Gel-One.
Payment limit per per dose, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Gel-One.
Payment limit per per dose, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gel-One | Zimmer Biomet | 50016-0957-11 | 1 | $524.063 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $524.063 | −$9.529 | per dose | Gel-one | v1, posted September 17, 2026 |
| 3Q26 | $533.592 | +$6.806 | per dose | Gel-one | v1, posted September 15, 2026 |
| 2Q26 | $526.786 | −$1.265 | per dose | Gel-one | v1, posted September 15, 2026 |
| 1Q26 | $528.051 | −$1.207 | per dose | Gel-one | v1, posted September 15, 2026 |
| 4Q25 | $529.258 | +$5.241 | per dose | Gel-one | v1, posted September 8, 2026 |
| 3Q25 | $524.017 | −$14.463 | per dose | Gel-one | v1, posted March 10, 2026 |
| 2Q25 | $538.48 | +$12.104 | per dose | Gel-one | v1, posted March 10, 2026 |
| 1Q25 | $526.376 | −$8.107 | per dose | Gel-one | v1, posted December 19, 2025 |
| 4Q24 | $534.483 | +$13.489 | per dose | Gel-one | v1, posted June 11, 2025 |
| 3Q24 | $520.994 | −$1.377 | per dose | Gel-one | v1, posted June 11, 2025 |
| 2Q24 | $522.371 | +$25.082 | per dose | Gel-one | v1, posted March 11, 2025 |
| 1Q24 | $497.289 | −$18.013 | per dose | Gel-one | v1, posted December 19, 2024 |
| 4Q23 | $515.302 | −$1.425 | per dose | Gel-one | v1, posted October 10, 2024 |
| 3Q23 | $516.727 | −$5.743 | per dose | Gel-one | v1, posted June 5, 2024 |
| 2Q23 | $522.47 | +$5.076 | per dose | Gel-one | v1, posted February 23, 2024 |
| 1Q23 | $517.394 | +$25.162 | per dose | Gel-one | v1, posted December 6, 2023 |
| 4Q22 | $492.232 | +$4.144 | per dose | Gel-one | v1, posted June 22, 2023 |
| 3Q22 | $488.088 | – | per dose | Gel-one | v1, posted June 9, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.